Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Frank

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2023
Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research InitiativeErlan Sanchez, Tim Wilkinson, Gillian Coughlan, et al.
Neurobiology of Aging|May 27, 2021
Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesAllison A Dilliott, Kelly M Sunderland, Paula M McLaughlin, et al.
Geroscience|March 16, 2022
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Alzheimer'S Research & Therapy|June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
Neurology|March 10, 2025
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular DiseasesErlan Sanchez, Gillian T Coughlan, Tim Wilkinson, et al.
The Journal of Prevention of Alzheimer'S Disease|February 1, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future researchEric E Smith, Natalie A Phillips, Howard H Feldman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2022
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortKelly M Sunderland, Derek Beaton, Stephen R Arnott, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 5, 2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseasesAllison A Dilliott, Stephanie A Berberian, Kelly M Sunderland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2023
Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research InitiativeErlan Sanchez, Tim Wilkinson, Gillian Coughlan, et al.
Neurobiology of Aging|May 27, 2021
Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesAllison A Dilliott, Kelly M Sunderland, Paula M McLaughlin, et al.
Geroscience|March 16, 2022
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Alzheimer'S Research & Therapy|June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
Neurology|March 10, 2025
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular DiseasesErlan Sanchez, Gillian T Coughlan, Tim Wilkinson, et al.
The Journal of Prevention of Alzheimer'S Disease|February 1, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future researchEric E Smith, Natalie A Phillips, Howard H Feldman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2022
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortKelly M Sunderland, Derek Beaton, Stephen R Arnott, et al.
Pageof 9